Doctor of Biological Sciences. His research interests focus on purinergic signaling in normal and cancer cells and immobilization of enzymes on carbon nanomaterials.

In his previous work related to purinergic signaling, he pays particular attention to P2X7 receptor isoforms, their variable expression in different tumor cells under induced differentiation conditions and the use of the resulting changes as a potential adjunct therapy to existing treatment strategies.

The research on carbon nanomaterials is based on studying the biocompatibility of the newly developed materials in vitro, as well as their potential use as carriers for enzymes with potential therapeutic applications, taking into account the nature of protein-substrate interactions.